A kind of protein complexes of cytochrome C with L-Arg was observed. Using L-Arg a strategy for probing the structural information of cytochrome C and protein complexes was established. At low pH solution multiply L-A...A kind of protein complexes of cytochrome C with L-Arg was observed. Using L-Arg a strategy for probing the structural information of cytochrome C and protein complexes was established. At low pH solution multiply L-Arg adducts were produced and the number of binding ligand was depended on the charge state. While in neutral solution only these complexes binding with single L-Arg ligand were produced.展开更多
活性先导化合物的发现及其靶点研究是药物研发成功的关键。近年来,为阐明先导化合物的作用靶标,已开发众多研究方法,如蛋白芯片(protein microarray)技术及酵母双杂交(yeast two hybrid)技术等。这些方法可以很好地观察体外蛋白的状...活性先导化合物的发现及其靶点研究是药物研发成功的关键。近年来,为阐明先导化合物的作用靶标,已开发众多研究方法,如蛋白芯片(protein microarray)技术及酵母双杂交(yeast two hybrid)技术等。这些方法可以很好地观察体外蛋白的状态,缺点有:(1)不易观察活细胞中蛋白状态;(2)蛋白的固定会因外部环境不稳定而表现出较大差异性;(3)蛋白易失活。展开更多
文摘A kind of protein complexes of cytochrome C with L-Arg was observed. Using L-Arg a strategy for probing the structural information of cytochrome C and protein complexes was established. At low pH solution multiply L-Arg adducts were produced and the number of binding ligand was depended on the charge state. While in neutral solution only these complexes binding with single L-Arg ligand were produced.
文摘活性先导化合物的发现及其靶点研究是药物研发成功的关键。近年来,为阐明先导化合物的作用靶标,已开发众多研究方法,如蛋白芯片(protein microarray)技术及酵母双杂交(yeast two hybrid)技术等。这些方法可以很好地观察体外蛋白的状态,缺点有:(1)不易观察活细胞中蛋白状态;(2)蛋白的固定会因外部环境不稳定而表现出较大差异性;(3)蛋白易失活。